GLYCATED HEMOGLOBIN (HbA1C)
ANVISA Registration Number: 10009010453LABTEST DIAGNOSTICA S/ASHANGHAI MEDCONN BIOTECHNOLOGY CO., LTD.Risk Class II
Device names
- Technical name
- GLYCATED HEMOGLOBIN (HbA1C)
- Risk class
- Class II
PT: HEMOGLOBINA GLICADA (HbA1C)
Registration details
- Registration Number
- 10009010453
- Process Number
- 25351220344202460
- CNPJ
- 16516296000138
Company information
- Registration Holder
- LABTEST DIAGNOSTICA S/A
- Manufacturer
- SHANGHAI MEDCONN BIOTECHNOLOGY CO., LTD.
- Manufacturing Country
- China
PT: CHINA, REPÚBLICA POPULAR
Dates and status
- Publication Date
- May 13, 2024
- Validity
- VIGENTE
- Last Updated
- 08/18/2026 19:00:00
About this record
Access comprehensive regulatory information for GLYCATED HEMOGLOBIN (HbA1C) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10009010453 and manufactured by SHANGHAI MEDCONN BIOTECHNOLOGY CO., LTD.. The registration is held by LABTEST DIAGNOSTICA S/A with validity until currently active (VIGENTE).
This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.